Search results
These Drugs Are the New First Line of Defense Against Migraine
Verywell Health via Yahoo News· 2 months agoIllustration by Julie Bang for Verywell Health Fact checked by Nick Blackmer Key Takeaways CGRP...
AbbVie (ABBV) Files Qulipta sNDA for Chronic Migraine Prevention
Zacks via Yahoo Finance· 2 years agoWith the latest approval for chronic migraine prevention, AbbVie's(ABBV) Qulipta becomes the only...
Menstrual Migraine: Role of Estrogen and Self-Care Tips
Verywell Health via Yahoo News· 9 months agoMenstrual migraines develop around a person's menstrual period, typically manifesting a couple of...
Huntington's treatment helps Teva beat profit estimates as CEO eyes newer drug opportunities
Reuters via Yahoo News· 10 months agoJERUSALEM (Reuters) -Teva Pharmaceutical Industries on Wednesday reported higher-than-expected...
Teva, GSK Put Up Bullish Fourth-Quarter Performances. Here's Where Novartis Fell Short.
Investor's Business Daily· 4 months agoTeva stock neared a profit-taking zone Wednesday, while GSK stock — a fellow pharma Goliath —...
Teva Retakes Its 200-Day Line After Second-Quarter Beat And Raise
Investor's Business Daily· 10 months agoTeva Pharmaceutical rode two drugs to a second-quarter beat Wednesday, and Teva stock galloped above...
TEVA Beats Q4 Earnings Estimates, Sales Miss & Stock Down
Zacks via Yahoo Finance· 1 year agoTeva Pharmaceutical Industries Limited TEVA reported fourth-quarter 2022 adjusted earnings of 71...
Teva sees return to growth after opioid settlement, shares jump
Reuters via Yahoo Finance· 2 years agoJERUSALEM (Reuters) -Teva Pharmaceutical Industries on Wednesday forecast mid-single digit revenue...
Teva says Israel-Hamas war not hurting production, eyes growth in 2024
Reuters via Yahoo News· 7 months agoJERUSALEM (Reuters) -Israel-based Teva Pharmaceutical Industries, the world's largest maker of...
Teva Pharm to launch Humira biosimilar as Q1 profit misses estimates
Reuters via Yahoo Finance· 1 month agoTeva Pharmaceutical Industries said it was set to launch its long awaited biosimilar of AbbVie's...